D.J. St. Germain’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$468K Sell
1,209
-117
-9% -$43.4K 0.02% 229
2026
Q1
$388K Sell
1,326
-9
-0.7% -$2.96K 0.02% 236
2025
Q4
$468K Hold
1,335
0.02% 224
2025
Q3
$431K Sell
1,335
-123
-8% -$38.3K 0.02% 228
2025
Q2
$567K Buy
1,458
+608
+72% +$245K 0.02% 202
2025
Q1
$370K Sell
850
-472
-36% -$189K 0.02% 223
2024
Q4
$488K Buy
1,322
+476
+56% +$199K 0.02% 215
2024
Q3
$440K Hold
846
0.02% 212
2024
Q2
$458K Sell
846
-53
-6% -$28K 0.02% 207
2024
Q1
$466K Hold
899
0.02% 203
2023
Q4
$424K Buy
899
+14
+2% +$6.47K 0.02% 204
2023
Q3
$385K Sell
885
-159
-15% -$72.1K 0.02% 207
2023
Q2
$464K Buy
+1,044
New +$482K 0.02% 191
2022
Q4
$113K Buy
922
+378
+69% +$192K 0.04% 117
2022
Q3
$263K Hold
544
0.02% 203
2022
Q2
$263K Hold
544
0.02% 203
2022
Q1
$267K Hold
544
0.02% 213
2021
Q4
$252K Hold
544
0.01% 225
2021
Q3
$203K Hold
544
0.01% 233
2021
Q2
$208K Buy
+544
New +$208K 0.01% 232

Other funds holding ELV

D.J. St. Germain's ELV Position: Q2 2026 in Review

D.J. St. Germain reduced its Elevance Health (ELV) stake by 8.8% in Q2 2026, selling an estimated $43.4K and leaving 1,209 shares worth $468K. The position accounts for 0.02% of the portfolio, ranked #229.

D.J. St. Germain first reported a position in ELV in Q2 2021 and has held it in 20 quarters since. The position peaked at $567K in Q2 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • D.J. St. Germain held 1,209 shares of Elevance Health worth $468K as of Q2 2026.
  • D.J. St. Germain sold 117 Elevance Health shares in Q2 2026, an estimated $43.4K.
  • Elevance Health made up 0.02% of D.J. St. Germain's portfolio in Q2 2026, its #229 holding.
  • D.J. St. Germain first reported a position in Elevance Health in Q2 2021 and has held it in 20 quarters since.
  • D.J. St. Germain's Elevance Health position peaked at $567K in Q2 2025.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on D.J. St. Germain's 13F filing for Q2 2026, filed 21 Jul 2026.